Analysis of 6,747 Pancreatic Neuroendocrine Tumors for a Proposed Staging System

Journal of Gastrointestinal Surgery

Volumn 15, Issue 1, 2011, Pages 175-183

  Martin, Robert C G ^a,h   Kooby, David A ^b   Weber, Sharon M ^c   Merchant, Nipun B ^d   Parikh, Alex A ^d   Cho, Clifford S ^c   Ahmad, Syed A ^e   Kim, Hong Jin ^f   Hawkins, William ^g   Scoggins, Charles R ^a  

^a UNIVERSITY OF LOUISVILLE HOSPITAL   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

^c University of Wisconsin Health   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^f UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h University of Louisville School of Medicine   (United States)

Author keywords

Neuroendocrine; Pancreatic; Staging

Indexed keywords

EID: 78751591386     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-010-1380-y     Document Type: Article

References (30)

1. Lam KY, Lo CY. Pancreatic endocrine tumour: a 22-year clinico-pathological experience with morphological, immunohistochemical observation and a review of the literature. Eur J Surg Oncol 1997; 23: 36-42.
2. Eriksson B, Oberg K. Neuroendocrine tumours of the pancreas. Br J Surg 2000; 87: 129-131.
3. Moldow RE, Connelly RR. Epidemiology of pancreatic cancer in Connecticut. Gastroenterology 1968; 55: 677-686.
4. Capella C, Heitz PU, Hofler H et al. Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch 1995; 425: 547-560.
5. Rindi G, Capella C, Solcia E. Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract. Q J Nucl Med 2000; 44: 13-21.
6. Rindi G, Kloppel G, Alhman H et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006; 449: 395-401.
7. Fischer L, Kleeff J, Esposito I et al. Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br J Surg 2008; 95: 627-635.
8. Bettini R, Boninsegna L, Mantovani W et al. Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours. Ann Oncol 2008; 19: 903-908.
9. La RS, Klersy C, Uccella S et al. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. Hum Pathol 2009; 40: 30-40.
10. Bilimoria KY, Bentrem DJ, Merkow RP et al. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. J Am Coll Surg 2007; 205: 558-563.
11. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 1958; 53: 457-481.
12. Royston P, Sauerbrei W. A new measure of prognostic separation in survival data. Statistics in Medicine 2004; 23: 723-748.
13. Schemper M, Henderson R. Predictive Accuracy and explained variation in Cox regression. Biometrics 2000; 56: 249-255.
14. Heagerty P, Lumley T, Pepe M. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000; 56: 337-344.
15. Efron B, Tibshirani R. An Introduction to the Bootstrap. New York, NY: Chapman & Hall; 1994.
16. Lusa L, Miceli R, Mariani L. Estimation of predictive accuracy in survival analysis using R and S-PLUS. Computer Methods and Programs in Biomedicine 2007; 87: 132-137.
17. Heagerty P, Saha P. survivalROC: Time-dependent ROC curve estimation from censored survival data. 2006.
18. Canty A. Resampling Methods in R: The Boot Package. R News 2002; 2: 2-7.
19. R Development Core Team. R: A language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2008.
20. Kooby DA, Gillespie T, Bentrem D et al. Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches. Ann Surg 2008; 248: 438-446.
21. Merchant N, Ayers GD, Schmidt CM, Kooby DA, Kim HJ, Weber SM, Martin RCG, Ahmed S, Sharp KS, Beauchamp RD, Parikh AA. Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits? J Am Coll. Surg. 2009: 208(5): 829-838; discussion 838-841.
22. Weber SM, Cho CS, Merchant N et al. Laparoscopic left pancreatectomy: complication risk score correlates with morbidity and risk for pancreatic fistula. Ann Surg Oncol 2009; 16: 2825-2833.
23. Schindl M, Kaczirek K, Kaserer K et al. Is the new classification of neuroendocrine pancreatic tumors of clinical help? World J Surg 2000; 24: 1312-1318.
24. Landry CS, Brock G, Scoggins CR et al. Proposed staging system for colon carcinoid tumors based on an analysis of 2, 459 patients. J Am Coll Surg 2008; 207: 874-881.
25. Landry CS, Brock G, Scoggins CR et al. A proposed staging system for small bowel carcinoid tumors based on an analysis of 6, 380 patients. Am J Surg 2008; 196: 896-903.
26. Landry CS, Brock G, Scoggins CR et al. A proposed staging system for gastric carcinoid tumors based on an analysis of 1, 543 patients. Ann Surg Oncol 2009; 16: 51-60.
27. Landry CS, Brock G, Scoggins CR et al. A proposed staging system for rectal carcinoid tumors based on an analysis of 4, 701 patients. Surgery 2008; 144: 460-466.
28. Landry CS, Woodall C, Scoggins CR et al. Analysis of 900 appendiceal carcinoid tumors for a proposed predictive staging system. Arch Surg 2008; 143: 664-670.
29. Landry CS, McMasters KM, Scoggins CR et al. Proposed staging system for gastrointestinal carcinoid tumors. Am Surg 2008; 74: 418-422.
30. Kazanjian KK, Reber HA, Hines OJ. Resection of pancreatic neuroendocrine tumors: results of 70 cases. Arch Surg 2006; 141: 765-769.